IU training Program in Molecular Physiology and Clinical Mechanisms of Lung Disea

 描述(由申请者提供)：此T-32培训申请是为了竞争性地更新当前的T32肺部培训计划，该计划的基础是印第安纳大学医学院，这是印第安纳州唯一的医学院。拟议的计划建立在当前培训奖的成功基础上，具有多学科、高度协作、 包括成熟的调查人员和高素质和敬业的导师。我们将继续让学员接触基础研究和临床转化研究的经典元素，我们在本地优势的基础上，融入了新技术和再生医学的强大组成部分。这一应用的新功能是与伊利诺伊大学儿科肺科的合作，这是因为人们认识到成人肺部疾病始于童年，甚至是产前，以及我们的同事在研究方面进行交叉培训的强大历史。鉴于我们项目的成功和发展，我们还提议增加实习生人数，在目前项目的三个博士后职位基础上增加一个博士后和一个博士后职位。增加一个博士前职位也将使我们能够更有效地招聘 未来肺部和重症监护医学的领导者在早期阶段。最后，我们建议为有兴趣的博士后提供一个生命科学创业培训的轨道，作为一个替代但仍然重要的科学职业轨道。我们的最终目标是培训研究人员，以加快肺部研究的进步，并弥合几十年来阻碍大多数肺部疾病患者的表型特征、有效预防干预和疾病修改甚至治疗药物发展的知识差距。我们坚定不移地致力于培训代表性不足的少数族裔人才，并得到实地领导人的强有力监督。

 DESCRIPTION (provided by applicant): This T-32 Training application is to competitively renew the current T32 pulmonary training program, anchored within the Indiana University School of Medicine, the only medical school in the state of Indiana. The proposed program builds on the success of the current training award, being multidisciplinary, highly collaborative, and including established investigators and highly qualified and dedicated mentors. We will continue to expose trainees to classical elements of basic and clinical-translational research, to which we incorporated novel technologies and a robust component of regenerative medicine, building on our local strengths. New in this application is a partnership with Pediatric Pulmonology at IU, fueled by the realization that adult lung diseases start in childhood or even prenatally, and by the strong history of cross training our fellows in research. Given the success and growth of our program, we are also proposing an increase in the number of trainees, adding one predoctoral and one postdoctoral spot to the three postdoctoral positions from the current program. The addition of one predoctoral position will also allow us to more efficiently to recruit future leaders of pulmonary and critical care medicine at an early stage. Finally, we propose to offer to interested postdocs a track for training in life science entrepreneurship, as an alternatie but yet important science career track. The ultimate goal is for us to train investigators that wil accelerate the advancements in lung research and close the gaps in knowledge that prevented for so many decades the development of phenotypic characterization, effective preventive intervention, and disease-modifying or even curative druts for most patients with lung disease. We maintain the strong commitment to training underrepresented minority talent and by a strong oversight from leaders in the field.